Literature DB >> 23026847

Open globe ocular trauma: functional outcome of eyes with no light perception at initial presentation.

Nishant G Soni1, Alain M Bauza, Jung H Son, Paul D Langer, Marco A Zarbin, Neelakshi Bhagat.   

Abstract

PURPOSE: To evaluate characteristics and prognostic factors for functional success in eyes that present with no light perception (NLP) after open globe trauma.
METHODS: The medical records of all subjects presenting to a single university referral center with visual acuity (VA) of NLP after sustaining an open globe eye injury from January 1, 2001, through June 30, 2010, were retrospectively analyzed to determine epidemiologic and clinical factors associated with visual outcomes.
RESULTS: Of the 73 NLP eyes (73 patients) that underwent primary repair and were included in the study, final VA was 20/100 in 1 eye (1%), counting fingers in 2 eyes (3%), hand motion in 9 eyes (12%), light perception in 5 eyes (7%), and NLP in 56 eyes (77%). Recovery of some vision on postoperative Day 1, pars plana vitrectomy operation, and Zone 2 injury were significantly associated with an improvement in final VA. Zone 3 injuries were the most likely to result in NLP final VA, although this difference was not statistically significant.
CONCLUSION: Visual recovery to light perception or better on postoperative Day 1 increases the likelihood of having a long-term improvement in VA. Pars plana vitrectomy may be beneficial in such eyes if posterior segment abnormalities are noted.

Entities:  

Mesh:

Year:  2013        PMID: 23026847     DOI: 10.1097/IAE.0b013e318263cefb

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  19 in total

1.  Prognostic factors for open-globe injuries: variables for poor visual outcome.

Authors:  Soner Guven; Ali Hakan Durukan; Cuneyt Erdurman; Murat Kucukevcilioglu
Journal:  Eye (Lond)       Date:  2018-09-26       Impact factor: 3.775

2.  Clinical characteristics and prognostic factors of scleral rupture due to blunt ocular trauma.

Authors:  O E Yucel; S Demir; L Niyaz; O Sayin; A Gul; N Ariturk
Journal:  Eye (Lond)       Date:  2016-09-02       Impact factor: 3.775

3.  Predictive factors of enucleation after open globe injuries.

Authors:  Effy Ojuok; Aditya Uppuluri; Paul D Langer; Marco A Zarbin; Loka Thangamathesvaran; Neelakshi Bhagat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-06-21       Impact factor: 3.117

4.  Enucleation in pediatric open globe injuries: demographics and risk factors.

Authors:  Siri Uppuluri; Aditya Uppuluri; Paul D Langer; Marco A Zarbin; Neelakshi Bhagat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-16       Impact factor: 3.535

5.  Epidemiologic characteristics and outcomes of open globe injury in Shanghai.

Authors:  Yong-Rong Ji; Dong-Qing Zhu; Hui-Fang Zhou; Xian-Qun Fan
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

6.  Reasonableness of surgical interventions in eyes with no light perception after severe ocular trauma.

Authors:  Wilfried Glatz; Marlene Glatz; Esther Halbwirth; Wolfgang List; Domagoj Ivastinovic; Andreas Wedrich
Journal:  Acta Ophthalmol       Date:  2021-05-05       Impact factor: 3.988

7.  Visual recovery following open globe injury with initial no light perception.

Authors:  Yong S Han; Shaheen C Kavoussi; Ron A Adelman
Journal:  Clin Ophthalmol       Date:  2015-08-11

8.  Risk factors for poor outcomes in patients with open-globe injuries.

Authors:  Rita D Page; Sumeet K Gupta; Thomas L Jenkins; Zeynel A Karcioglu
Journal:  Clin Ophthalmol       Date:  2016-08-01

9.  Clinical Review of Ocular Traumas Resulting in Enucleation or Evisceration in a Tertiary Eye Care Center in Hungary.

Authors:  Gábor Tóth; Milán Tamás Pluzsik; Béla Csákány; Gábor László Sándor; Olga Lukáts; Zoltán Zsolt Nagy; Nóra Szentmáry
Journal:  J Ophthalmol       Date:  2021-05-27       Impact factor: 1.909

10.  Traumatic ruptured globe eye injuries in a large urban center.

Authors:  Eitan S Burstein; Douglas R Lazzaro
Journal:  Clin Ophthalmol       Date:  2013-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.